Mayo Q & A: COVID-19 Variants and the Evolving Science

Mayo Q & A: COVID-19 Variants and the Evolving Science

This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021

Guest: Gregory A. Poland, M.D. (@drgregpoland)

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

People may be curious, confused or critical of what seem to be changing messages related to the COVID-19 pandemic.

Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, reminds folks that messages change because data changes and the science evolves.

"As we learn new science, we use that science to modify our recommendations," says Dr. Poland. "It's not that scientists are flip-flopping. It is that new data allows us to begin expanding those recommendations."

For instance, COVID-19 cases and deaths in the U.S. are currently declining. But, Dr. Poland says, there are new data predicting the possibility of another surge of COVID-19 infections in March because of U.K. variant transmission.

In this Mayo Clinic Q&A podcast Dr. Poland talks about several issues, including the U.K. variant, vaccine development and the public’s COVID-19 fatigue.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Avsnitt(500)

Heart Health Series | Cardiotoxicity of Cancer Therapies

Heart Health Series | Cardiotoxicity of Cancer Therapies

Host: Darryl S. Chutka, M.D.  Guest: Balaji Tamarappoo, M.D., Ph.D.  With advances in oncology, patients are living longer than ever following a diagnosis of cancer. Newer treatments have dramatically...

24 Feb 26min

Heart Health Series | Pericardial Disease

Heart Health Series | Pericardial Disease

Host: Darryl S. Chutka, M.D.  Guest: Hema Narayanasamy, M.B.B.S.  Pericardial disease represents a spectrum of both inflammatory and non-inflammatory disorders which involve the pericardium, with acut...

17 Feb 28min

The Power of Intervals: High Intensity Interval Training and Reducing Cardiovascular Risk

The Power of Intervals: High Intensity Interval Training and Reducing Cardiovascular Risk

Host: Darryl S. Chutka, M.D.  Guest: Stephen Kopecky, M.D.  We have a variety of pharmacologic options and lifestyle changes we recommend to our patients to reduce their cardiovascular risks. One freq...

10 Feb 20min

Heart Health Series | Bicuspid Aortic Valve Disease

Heart Health Series | Bicuspid Aortic Valve Disease

Host: Darryl S. Chutka, M.D.  Guest: George Wang, M.D.  Bicuspid aortic valve is a relatively common congenital heart disease. It can be associated with other genetic disorders such as Turner’s Syndro...

5 Feb 29min

Heart Health Series | Cardiac Amyloidosis

Heart Health Series | Cardiac Amyloidosis

Host: Darryl S. Chutka, M.D.  Guest: Julie Rosenthal, M.D.  Cardiac amyloidosis is not a common condition, but it is important for primary care clinicians to recognize it in our patients. It’s commonl...

3 Feb 29min

Concussions: What Every Primary Care Provider Should Know

Concussions: What Every Primary Care Provider Should Know

Host: Darryl S. Chutka, M.D. Guest: Matthew B. Anastasi, M.D. Patients with concussions are commonly seen in primary care practices and concussions don’t spare any particular age group. Children, youn...

27 Jan 27min

Rx for Weight Loss: A Closer Look Series "The Wins of Losing: GLP-1 Agonists and Reducing Heart Disease Risk"

Rx for Weight Loss: A Closer Look Series "The Wins of Losing: GLP-1 Agonists and Reducing Heart Disease Risk"

Host: Darryl S. Chutka, M.D.  Guest: Stephen Kopecky, M.D.  One of the biggest surprises we’ve seen in medicine in the past several years has been the numerous health benefits realized from the GLP-1 ...

20 Jan 20min

Rx for Weight Loss: A Closer Look Series "Controversies & Future of GLP-1 Medications"

Rx for Weight Loss: A Closer Look Series "Controversies & Future of GLP-1 Medications"

Host: Darryl S. Chutka, M.D.  Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B.  The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially ...

15 Jan 24min

Populärt inom Utbildning

historiepodden-se
rss-bara-en-till-om-missbruk-medberoende-2
det-skaver
harrisons-dramatiska-historia
nu-blir-det-historia
not-fanny-anymore
allt-du-velat-veta
sektledare
johannes-hansen-podcast
alska-oss
roda-vita-rosen
rss-viktmedicinpodden
rss-foraldramotet-bring-lagercrantz
rss-sjalsligt-avkladd
rss-max-tant-med-max-villman
rikatillsammans-om-privatekonomi-rikedom-i-livet
sa-in-i-sjalen
rss-beratta-alltid-det-har
i-vantan-pa-katastrofen
rss-om-vi-ska-vara-arliga